Abstract:Antibiotics are frequently used to treat bacterial infections; however, they affect not only the target pathogen but also commensal gut bacteria. They may cause the dysbiosis of human intestinal microbiota and consequent metabolic alterations, as well as the spreading of antibiotic resistant bacteria and antibiotic resistance genes (ARGs).In vitroexperiments by simulator of the human intestinal microbial ecosystem (SHIME) can clarify the direct effects of antibiotics on different regions of the human intestinal microbiota, allowing complex human microbiota to be stably maintained in the absence of host cells. However, there are very few articles added the antibiotics into thisin vitromodel to observe the effects of antibiotics on the human intestinal microbiota. To date, no studies have focused on the correlations between the bloomed pathogens caused by amoxicillin (AMX) exposure and increased functional pathway genes as well as ARGs. This study investigated the influence of 600 mg day(-1)AMX on human intestinal microbiota using SHIME. The impact of AMX on the composition and function of the human intestinal microbiota was revealed by 16S rRNA gene sequencing and high-throughput quantitative PCR. The results suggested that: (i) AMX treatment has tremendous influence on the overall taxonomic composition of the gut microbiota by increasing the relative abundance ofKlebsiella[linear discriminant analysis (LDA) score = 5.26] andBacteroides uniformis(LDA score = 4.75), as well as taxonomic diversity (Simpson,P= 0.067,T-test; Shannon,P= 0.061,T-test), and decreasing the members ofParabacteroides(LDA score = 4.18),Bifidobacterium(LDA score = 4.06), andPhascolarctobacterium(LDA score = 3.95); (ii) AMX exposure significantly enhanced the functional pathway genes and beta-lactam resistance genes, and the bloomed pathogens were strongly correlated with the metabolic and immune system diseases gene numbers (R= 0.98,P< 0.001) orbl2_lenandbl2be_shv2abundance (R= 0.94,P< 0.001); (iii) the changes caused by AMX were "SHIME-compartment" different with more significant alteration in ascending colon, and the effects were permanent, which could not be restored after 2-week AMX discontinuance. Overall results demonstrated negative side-effects of AMX, which should be considered for AMX prescription.

UPLC/Q‐TOF–MS‐based metabolomics and molecular docking analysis of Bifidobacterium adolescentis exposure to levofloxacin

Effect Of The Short-Term Use Of Fluoroquinolone And Beta-Lactam Antibiotics On Mouse Gut Microbiota

Influences of Levofloxacin Salts on the Metabolism of Escherichia Coli by Microcalorimetry

Effect Of Lactobacillus On Toll-Like Receptors Expression And Bacterial Translocation In Antibiotic Diarrhea Rats

Advances in Lactobacillus Restoration for Β-Lactam Antibiotic-Induced Dysbiosis: A System Review in Intestinal Microbiota and Immune Homeostasis

Clostridium Butyricum Combined with Bifidobacterium Infantis Probiotic Mixture Restores Fecal Microbiota and Attenuates Systemic Inflammation in Mice with Antibiotic-Associated Diarrhea.

Clostridium Butyricumcombined Withbifidobacterium Infantisprobiotic Mixture Restores Fecal Microbiota and Attenuates Systemic Inflammation in Mice with Antibiotic-Associated Diarrhea

Reduced bacterial resistance antibiotics with improved microbiota tolerance in human intestinal: Molecular design and mechanism analysis

Effect of traditional chinese medicine (TCM) and its fermentation using Lactobacillus plantarum on ceftriaxone sodium-induced dysbacteriotic diarrhea in mice

Amoxicillin Increased Functional Pathway Genes and Beta-Lactam Resistance Genes by Pathogens Bloomed in Intestinal Microbiota Using a Simulator of the Human Intestinal Microbial Ecosystem

Effects of Bacteroides-Based Microecologics against Antibiotic-Associated Diarrhea in Mice

The intracellular concentrations of fluoroquinolones determined the antibiotic resistance response of Escherichia coli

Bifidobacterium adolescentis CCFM1285 combined with yeast β-glucan alleviates gut microbiota and metabolic disturbances in mice with antibiotic-associated diarrhea

A comparative study of the effects of different fucoidans on cefoperazone-induced gut microbiota disturbance and intestinal inflammation

Colistin and amoxicillin combinatorial exposure alters the human intestinal microbiota and antibiotic resistome in the simulated human intestinal microbiota

A single-cell nanocoating of probiotics for enhanced amelioration of antibiotic-associated diarrhea

Effect of Fermented Traditional Chinese Prescription With Lactobacillus Plantarum on Dysbacteriotic Diarrhea Mice Induced by Ceftriaxone Sodium

Antibiotics enhancing drug-induced liver injury assessed for causality using Roussel Uclaf Causality Assessment Method: Emerging role of gut microbiota dysbiosis

Spatial analysis of murine microbiota and bile acid metabolism during amoxicillin treatment

Determining the role of a probiotic in the restoration of intestinal microbial balance by molecular and cultural techniques

Effects of antibiotic cocktail on the fecal microbiota and their potential correlation of local immune response